Serum interleukin-17 in primary Sjögren's syndrome: Association with disease duration and parotid gland swelling

Clinical and Experimental Rheumatology

Volumn 33, Issue 1, 2015, Pages 129-

  Alunno, A ^a   Bistoni, O ^a   Caterbi, S ^a   Bartoloni, E ^a   Cafaro, G ^a   Gerli, Roberto ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 17; BIOLOGICAL MARKER; IL17A PROTEIN, HUMAN;

ADULT; CLINICAL ARTICLE; CORRELATIONAL STUDY; DISEASE ASSESSMENT; DISEASE ASSOCIATION; DISEASE DURATION; EULAR SJOGRENS SYNDROME DISEASE ACTIVITY INDEX; FEMALE; HUMAN; LETTER; MEDICAL HISTORY; MIDDLE AGED; MINOR SALIVA GLAND; PAROTID GLAND DISEASE; PAROTID GLAND SWELLING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SJOEGREN SYNDROME; TH17 CELL; BLOOD; IMMUNOLOGY; MULTIVARIATE ANALYSIS; PAROTID GLAND; PATHOLOGY; PROGNOSIS; RISK; TIME;

BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKIN-17; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PAROTID GLAND; PROGNOSIS; SJOGREN'S SYNDROME; TIME FACTORS;

EID: 84928701906     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. NGUYEN CQ, YIN H, LEE BH et al.: Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther 2010; 12: R220.
2. LIN X, RUI K, DENG J et al.: Th17 cells play a critical role in the development of experimental Sjögren's syndrome. Ann Rheum Dis 2014 Feb 26 [Epub ahead of print].
3. CICCIA F, GUGGINO G, RIZZO A et al.: Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome. Rheumatology (Oxford) 2014; 53: 1313-20.
4. NGUYEN CQ, HU MH, LI Y et al.: Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome. Arthritis Rheum 2008; 58: 734-74.
5. KATSIFIS GE, REKKA S, MOUTSOPOULOS NM et al.: Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis. Am J Pathol 2009; 175: 1167-77.
6. FEI Y, ZHANG W, LIN D et al.: Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren's syndrome. Clin Rheumatol 2014; 33: 523-9.
7. SEROR R, GOTTENBERG JE, DEVAUCHELLE-PENSEC V et al.: ESSDAI and ESSPRI: EULAR indexes for a complete picture of primary Sjögren's syndrome patients. Arthritis Care Res (Hoboken) 2013; 65: 1358-64.
8. ALUNNO A, BISTONI O, BARTOLONI E et al.: IL-17-producing CD4-CD8-T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjögren's syndrome. Ann Rheum Dis 2013; 72: 286-92.
9. ALUNNO A, CARUBBI F, BISTONI O et al.: CD4-CD8-T-cells in primary Sjögren's syndrome: Association with the extent of glandular involvement. J Autoimmun 2014; 51: 38-43.